-
Fund Dashboard
- Holdings
Amplify Treatments, Testing and Advancements ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | 955.23 k | 3.93 k shares | 10.34 | Common equity | Long | USA |
First American Government Obligations Fund | 919.61 k | 919.61 k shares | 9.96 | Short-term investment vehicle | Long | USA |
LH Laboratory Corporation of America Holdings | 601.98 k | 2.96 k shares | 6.52 | Common equity | Long | USA |
DGX Quest Diagnostics Incorporated | 563.26 k | 4.12 k shares | 6.10 | Common equity | Long | USA |
BNTX BioNTech SE | 463.28 k | 5.77 k shares | 5.02 | Common equity | Long | Germany |
MRNA Moderna, Inc. | 450.54 k | 3.79 k shares | 4.88 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 407.53 k | 5.40 k shares | 4.41 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 406.09 k | 64.26 k shares | 4.40 | Common equity | Long | USA |
BIO Bio-Rad Laboratories, Inc. | 369.79 k | 1.35 k shares | 4.00 | Common equity | Long | USA |
ZLAB Zai Lab Limited | 356.91 k | 20.60 k shares | 3.86 | Common equity | Long | China |
DVAX Dynavax Technologies Corporation | 321.46 k | 28.63 k shares | 3.48 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 310.64 k | 9.17 k shares | 3.36 | Common equity | Long | UK |
QDEL QuidelOrtho Corporation | 305.29 k | 9.19 k shares | 3.31 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 278.93 k | 45.13 k shares | 3.02 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 264.82 k | 29.76 k shares | 2.87 | Common equity | Long | USA |
NVAX Novavax, Inc. | 253.34 k | 20.01 k shares | 2.74 | Common equity | Long | USA |
OPK OPKO Health, Inc. | 190.54 k | 152.43 k shares | 2.06 | Common equity | Long | USA |
CVAC CureVac N.V. | 166.78 k | 49.05 k shares | 1.81 | Common equity | Long | Germany |
HLVX HilleVax, Inc. | 157.24 k | 10.87 k shares | 1.70 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 143.42 k | 5.89 k shares | 1.55 | Common equity | Long | USA |
FLGT Fulgent Genetics, Inc. | 128.39 k | 6.54 k shares | 1.39 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 127.53 k | 41.27 k shares | 1.38 | Common equity | Long | USA |
SIGA SIGA Technologies, Inc. | 118.05 k | 15.55 k shares | 1.28 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 116.67 k | 32.23 k shares | 1.26 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 114.63 k | 114.63 k shares | 1.24 | Short-term investment vehicle | Long | USA |
LLY Eli Lilly and Company | 87.82 k | 97.00 shares | 0.95 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 87.61 k | 1.28 k shares | 0.95 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 87.24 k | 56.28 k shares | 0.94 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 85.13 k | 81.00 shares | 0.92 | Common equity | Long | USA |
ABBV AbbVie Inc. | 83.02 k | 484.00 shares | 0.90 | Common equity | Long | USA |
JNJ Johnson & Johnson | 81.41 k | 557.00 shares | 0.88 | Common equity | Long | USA |
ABT Abbott Laboratories | 81.26 k | 782.00 shares | 0.88 | Common equity | Long | USA |
SNY Sanofi | 79.91 k | 1.65 k shares | 0.87 | Common equity | Long | France |
PFE Pfizer Inc. | 79.21 k | 2.83 k shares | 0.86 | Common equity | Long | USA |
AZN AstraZeneca PLC | 78.69 k | 1.01 k shares | 0.85 | Common equity | Long | UK |
EBS Emergent BioSolutions Inc. | 78.16 k | 11.46 k shares | 0.85 | Common equity | Long | USA |
TAK Takeda Pharmaceutical Company Limited | 77.96 k | 6.03 k shares | 0.84 | Common equity | Long | Japan |
MRK Merck & Co., Inc. | 77.38 k | 625.00 shares | 0.84 | Common equity | Long | USA |
GSK GSK plc | 75.58 k | 1.96 k shares | 0.82 | Common equity | Long | UK |
OSUR OraSure Technologies, Inc. | 68.91 k | 16.18 k shares | 0.75 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 60.97 k | 18.42 k shares | 0.66 | Common equity | Long | USA |
ENTA Enanta Pharmaceuticals, Inc. | 60.08 k | 4.63 k shares | 0.65 | Common equity | Long | USA |
RENB Renovaro Biosciences Inc. | 57.24 k | 32.71 k shares | 0.62 | Common equity | Long | USA |
CRMD CorMedix Inc. | 52.06 k | 12.02 k shares | 0.56 | Common equity | Long | USA |
INO Inovio Pharmaceuticals, Inc. | 46.43 k | 5.75 k shares | 0.50 | Common equity | Long | USA |
XBIT XBiotech Inc. | 34.72 k | 6.75 k shares | 0.38 | Common equity | Long | USA |
IVVD Invivyd, Inc. | 29.10 k | 26.46 k shares | 0.32 | Common equity | Long | USA |
VXRT Vaxart, Inc. | 26.17 k | 39.21 k shares | 0.28 | Common equity | Long | USA |
IFRX InflaRx N.V. | 22.72 k | 13.06 k shares | 0.25 | Common equity | Long | Germany |
CMRX Chimerix, Inc. | 17.41 k | 19.87 k shares | 0.19 | Common equity | Long | USA |
GRTSQ Gritstone bio, Inc. | 14.88 k | 24.07 k shares | 0.16 | Common equity | Long | USA |
ANTX AN2 Therapeutics, Inc. | 14.22 k | 6.61 k shares | 0.15 | Common equity | Long | USA |
CVM CEL-SCI Corporation | 13.93 k | 12.01 k shares | 0.15 | Common equity | Long | USA |
CUE Cue Biopharma, Inc. | 13.37 k | 10.79 k shares | 0.14 | Common equity | Long | USA |
Gurnet Point Capital LLC
|
0.00 | 16.56 k shares | 0.00 | Common equity | Long | USA |
AstraZeneca PLC
|
0.00 | 11.79 k shares | 0.00 | Common equity | Long | UK |